RX modena and Randox Reagents used in COVID-19 hospital in India

Home - Archives for Randox Communications

RX modena and Randox Reagents used in COVID-19 hospital in India

News       RX modena       COVID-19

 

 

18 June 2020

RX modena and Randox Reagents used in COVID-19 hospital in India

Randox Laboratories has installed an RX modena into a COVID-19 hospital in India; the Netaji Subhash Chandra Bose Medical College in Madhya Pradesh state.

The installation, which marks the first RX modena to be used in an Indian Government Medical College, replaces existing instrumentation in the Medical College laboratory, an initiative which was driven by College Dean Dr. Pradeep Kumar Kasar and Head of Department Dr. Ashok Kumar Sahu.

The RX modena will cater for an additional 38 samples compared to the previous instrumentation, and is running a range of biochemistry tests that play a pivotal role in COVID-19 patient management, including C-Reactive Protein (CRP), Ferritin, and Lactate Dehydrogenase (LDH).

Dr. Ashok Kumar Sahu, Head of Biochemistry at Netaji Subhash Chandra Bose Medical College, commented;

“We are very pleased with the performance of the RX modena, and in particular with its wide menu of tests that can be utilized for COVID-19 patient management. Its high throughput and versatility have been a great support for the clinicians working in our COVID-19 hospital, in determining risk stratification, disease progression, and response to treatment.”

The RX modena is a high volume, floor standing, fully automated clinical chemistry analyser with a world leading test menu which covers specific proteins, lipids, therapeutic drugs, antioxidants, diabetes and veterinary testing. The versatile analyser offers advanced methodologies with excellent correlation to the gold standard, and excellent reagent CV ranges.

Shail Dholabhai, Randox India Sales Manager, commented;

 “We are delighted that the team at Netaji Subhash Chandra Bose Medical College have chosen the RX modena to fulfil the testing requirements of this COVID-19 hospital. Offering an unrivalled test menu of routine and specialized chemistries, the RX modena provides laboratories with the superior precision, reliability and accuracy that the Randox RX series is renowned for.

“Capable of performing a total of 1200 tests per hour including ISE, the RX modena presents a new class of efficiency which will result in faster and more accurate diagnoses, and ultimately, lead to better patient outcomes.”

Benefits of the RX modena

  • Capable of performing 800 photometric and a total of 1200 tests per hour including ISE.
  • World-leading extensive test menu covering routine chemistries, specific proteins, lipids, antioxidants, cardiac, diabetes and veterinary testing, offering cost savings through consolidation of routine and novel tests on a single platform.
  • Economic platform with low water consumption of less than 20 litres per hour saving on consumable costs. The RX modena also requires less than 5 minutes minimal maintenance.
  • Interactive touch-screen technology with integrated barcode readers for reagent and sample identification. Increased functionality with 13 wavelengths generated via diffraction grating (340-800nm) ensuring a multitude of chemistries are possible on one system.
  • Easy-to-use advanced Microsoft 10 software with a built-in Inventory Management System calculating the number of tests remaining, providing alerts of shortages and expired reagents and calibrators. The RX modena also features automatic test re-run function and sample dilution.
  • Dedicated reagent and sample pipettes to minimise the risk of errors and contamination. The RX modena also features a continuous loading hatch to allow for samples to be analysed quickly and easily during a run.
  • Advanced QC capabilities with daily, monthly and batch QC with data archiving, Levey-Jennings charts and automatic QC and calibration. There are also 7 different calibration options available.

For further information about the RX modena click here. 

For information about laboratory tools for COVID-19 patient management please click here.

For other enquiries please contact marketing@randox.com

 

Want to know more about Randox?

Contact us or visit our homepage to view more.

Our Randox Products and Services

REAGENTS

RX SERIES

ACUSERA

BIOCHIP


Matt Hancock and Lord Bethell support Randox in call for future focus on diagnostics

News       About Us       COVID-19

 

29 June 2020

Matt Hancock and Lord Bethell support Randox in call for future focus on diagnostics

Matt Hancock and Lord Bethell support Randox in call for future focus on diagnostics

In a recent Opinion Piece in The Daily Telegraph, our Managing Director Dr Peter FitzGerald stressed the value of diagnostics, the important role it plays in public health, and the contribution it has made specifically during the COVID-19 pandemic.

Whilst regrettable that it has taken a pandemic to bring the health diagnostics sector into focus, it is a positive step forward for healthcare that the huge national and international scope of our sector is now rightly acknowledged.

Indeed, Dr FitzGerald’s commentary was acknowledged by both the Secretary of State for Health, Matt Hancock, and the Minister for Innovation, Jim Bethell.

The Secretary of State noted that “Randox have played a vital role in building our global-scale diagnostics capacity.”

    It is clear that the diagnostics industry, inclusive of the work Randox has done in the field, has had a positive impact in the fight against COVID-19. We know that testing at scale is the most effective way to both save lives, and ensure a timely return to a more normal society.

    We are very proud of our staff, for their ongoing support, and for their commitment to the work that we do, which is making a real and positive difference.

    You can read Dr FitzGerald’s full Opinion Piece for The Daily Telegraph, on our own website, by clicking here.

    For further information please contact randoxpr@randox.com or phone 028 9442 2413

    Want to know more about Randox?

    Contact us or visit our homepage to view more.

    Our Randox Products and Services

    REAGENTS

    RX SERIES

    ACUSERA

    BIOCHIP


    COVID-19 has shown UK leadership on diagnostics; we can now become a world leader

    News       About Us       COVID-19

     

    25 June 2020

    COVID-19 has shown UK leadership on diagnostics

    COVID-19 has shown UK leadership on diagnostics; we can now become a world leader

    An Opinion Piece by Dr Peter FitzGerald, Managing Director of Randox Laboratories, in The Daily Telegraph

    When I founded Randox Laboratories in 1982 in Antrim, Northern Ireland, I could not have envisaged that today we would be manufacturing more clinical diagnostic products than any other company in the UK. Whilst I am incredibly proud that Randox is taking a leading role in the national Covid-19 testing effort, it is deeply regrettable that it has taken this pandemic to bring the UK’s health diagnostics sector into focus.

    The pandemic represents the biggest diagnostics and health infrastructure challenge of modern times.  It has forced and necessitated a herculean collaborative effort from Government, the NHS and the private sector. This partnership has delivered a new trust and information sharing network which bodes well for the future.

    Ministers now know what we can do and rightly acknowledge the huge national and international scope of our sector and for global UK leadership and new skilled jobs.  The Government is right to highlight and reflect that too many of these critical sectors and supplies have been allowed to be offshored in recent years. This has consequently had implications for patient care and the support available for health workers.

    In March, the World Health Organisation’s Director General, Tedros Adhanom Ghebreyesus, said that he had a simple message to countries on how to deal with the COVID-19 outbreak that was sweeping the globe, this message was ‘Test, test, test.’ In the UK, mass testing was, at that time, simply not possible. Indeed, the Health Secretary, Matthew Hancock, acknowledged  that it was the lack of a significant domestic diagnostic industry that had impeded the Government’s initial efforts on testing, which is why we were behind Germany and other states.  He was right and much has already been done to re-shore capacity and re-set this policy alongside understanding the importance for future British sector leadership.

    Going forward, we can and must deliver a new and much tighter partnership between the NHS and private sector across diagnostics and preventative healthcare. Improved communication, co-operation and partnerships will grow British sector expertise, jobs and skills.  The potential for British leadership and success here is huge.

    Earlier this month, I had the pleasure of welcoming Northern Ireland Secretary, Brandon Lewis MP to see our new £30m specialist Covid-19 testing hub at the Randox Science Park in Northern Ireland.  This investment will create 200 new science, engineering and manufacturing jobs at the facility on top of our existing workforce. It was fast-tracked over the space of four weeks and is the first step in a wider diagnostics investment programme as part of Randox’s efforts to enhance our national Covid testing capacity.

    A wider appreciation of the value and resource support for diagnostics testing and preventative health policy is now overdue and timely especially when you consider that seventy per cent of all medical decisions are based on the results of lab tests.  This testing must now account for more than the two per cent of the national healthcare budget.   Alongside our major focus on R&D, our scientists work on pioneering research into a range of common illnesses such as cancer, cardiovascular disease and Alzheimer’s disease. With around twenty five percent of turnover reinvested in R&D, Randox has more new tests in development than any other diagnostic company.  Our products are used across hospitals and veterinary laboratories, food testing, forensic toxicology and life sciences.

    Randox labs have spent over £305 million researching the thousands of biomarkers present in our bodies and have identified the gold standard in testing. Our patented Biochip Array Technology has revolutionized the diagnostics industry by offering a unique testing platform which allows multiple tests to be carried out from a single patient sample. On Covid, we have been able to include two tests on the same biochip; one specific and one confirmatory as recommended by the World Health Organisation.

    The ambition and determination to build a world-beating British diagnostics sector is overdue and right.  It offers so many advantages ranging from a healthier and happier population which lives longer to more skilled jobs in a sector which works hand in glove with our world beating academia and NHS.  The pandemic has rightly brought the UK’s diagnostics capability into sharp focus, and it is paramount that when we move to a post-Covid world, we take what we have learned from this crisis and build a self-reliant sector fit for the future.

      For further information please email randoxpr@randox.com

       

      Want to know more about Randox?

      Contact us or visit our homepage to view more.

      Our Randox Products and Services

      REAGENTS

      RX SERIES

      ACUSERA

      BIOCHIP


      We Are Randox | How Kelly Mon became Deputy Testing Coordinator for COVID-19

      About Us       News        Contact

      22 June 2020

      How Kelly Mon became Deputy Testing Coordinator for COVID-19

       

      We Are Randox | How Kelly Mon became Deputy Testing Coordinator for COVID-19

      In support of our new £30m COVID-19 laboratories, we are hiring 200 new staff across Engineering, Manufacturing and Science.

      For an idea of what it’s like to be part of the COVID-19 testing programme at Randox, we spoke to Deputy Coordinator Manager Kelly Mon.

      Kelly spoke to us about what a typical day in COVID-19 testing looks like, the career path she took to her current role, and her advice for a successful job search.

      Name: Kelly Mon

      Job Title: Deputy Co-Ordinator Manager

      Department: COVID-19 Testing

      Kelly, what did you study and where?

      After secondary school, I studied a BTEC National Diploma in Applied Science (Medical) in Belfast Met in Castlereagh, and then moved on to study Biomedical Science at Ulster University in Coleraine. I later studied part time for an MSc in Stratified Medicine.

      Give a brief outline of your career to date

      I trained as a Biomedical Scientist in Antrim Area Hospital for one year to gain a recognized certification from the Institute of Biomedical Science. When I graduated I started as a Laboratory Analyst at Randox Clinical Laboratory Services, where I ran health tests on our patented Biochip Technology. After a short time, I became a Clinical Team Leader managing a number of clinical trials for companies and universities. Recently I have been promoted to Deputy Co-Ordinator Manager for our COVID-19 testing programme.

      Kelly Mon

      Are there alternative routes into the job?

      For a job in Clinical Research you would ideally have a BSc in Biomedical Science, Biochemistry or Life Sciences, and a Diploma in Professional Practice. Alternatively, if you have a degree in another area we have a scheme at Randox that allows graduates the chance to rotate throughout departments, and many good candidates are offered positions at the end. There are also apprenticeships and student placements available.

      What does a typical day look like for you?

      A typical day in clinical trials usually involves running patient blood or urine samples on Randox Biochips that have been custom-made to suit that particular project. We work to tight deadlines, have regular updates with internal staff and customers, and conduct data analysis and reports. A typical day working on COVID-19 testing involves lots of PPE, and constant communication between a wide range of staff and departments. In my role I oversee our quality control, create and communicate important procedures, and visit the lab to make sure my staff are doing well.

      Is this what you always wanted to do?

      Whilst I knew that I liked science, I wasn’t sure what job I wanted to do. No one in my circle had ever gone on to study at university so I hadn’t considered it an option. I couldn’t even imagine that I could become a scientist.

       What are the best and most challenging aspects of the job?

      For me, the best aspect of any job is the people and at Randox I work with a great bunch. I also like the fact that there is career progression for people who put in the work to get it, and that you are trained to perform all tasks, not just one part of the work flow. The most challenging aspect of the job at times is the intensity of the workload, which is why organizational skills and the ability to keep calm under pressure are key in this job.

      Why is what you do important?

      There is that old saying that your health is your wealth and I’m proud to work for a healthcare company providing high quality health diagnostics. These products are used every day to assist in the detection of a wide range of diseases to provide the earliest possible diagnosis and improved patient outcomes. In my department the clinical trials we manage help to detect biomarkers of disease and determine treatment efficacy, which is important to identify less invasive methods of diagnosis, and more tailored ways to treat each patient.

      What advice would you give anyone looking to follow a similar career path?

      It’s important in any career to work hard and stick at it. I dropped out of two courses before I started the BTEC Diploma. I could have given up when times were hard, but I stuck with it and here I am sharing what I’ve learnt throughout my career. If you are planning specifically to study Biomedical Science, the advice I would give is to choose a course with a placement. My own course had a one-year placement in an NHS hospital, and the experience in a professional environment that gave me key laboratory skills was invaluable. It also gets you contacts in the industry which is always helpful.

      If you weren’t doing this what would you like to do?

      I love my job, I love my career and I love the people I work with so honestly, I wouldn’t choose any other career path!

       Describe your ideal day off.

      My ideal day off work involves pyjamas, junk food and good old Netflix.

      And finally, what’s the key to any successful job search?

      Sometimes job searching can be tiresome and after a while you start to apply without properly researching, but the key to any successful job search is preparation. Start by giving your CV an update and get someone – perhaps your university careers team, or a friend or family member – to proof-read it. Or, if you don’t have any other help, you can begin by searching CV templates on the internet. Personally I would advise that you include some interesting hobbies to make your application stand out. You would be surprised how things seemingly unrelated to a particular job will keep you in the recruiter’s mind. Then come up with some possible questions and think of the answers you might give before you go for interview.

      We are delighted to have Kelly with us at Randox as part of our COVID-19 testing programme.

       

      For current vacancies at Randox please visit careers.randox.com

      For more We Are Randox stories about our amazing colleagues, make sure to follow us on Facebook, Instagram and Twitter and follow the hashtag #WeAreRandox.

      For further information please email recruitment@randox.com or phone 028 9442 2413.

       

      Want to know more?

      Contact us or visit our Randox Careers

      Find out more about Randox Careers

      Careers News

      Vacancies

      Our People

      Careers Website


      COVID-19 Testing: PCR (Diagnostic) vs Antibody

      News       About Us       Randox Health

       

      18 June 2020

      COVID-19 Testing: PCR (Diagnostic) vs Antibody

      The advice from the World Health Organisation in relation to the COVID-19 pandemic has been simple; Test. Test. Test.

      But what are the different types of COVID-19 tests and what are they used for?

       

      Diagnostic (PCR) Testing

      This type of testing detects SARS-CoV-2 (the virus that causes COVID-19) within the body and will tell you if you currently have COVID-19. PCR tests cannot tell you if you have had past infection.

      Sample collection for a PCR test can vary, though it is usually in the form of a swab, which will gather an individual’s nasopharyngeal (nose and throat) secretions.

      PCR tests for COVID-19 all use methods that detect a specific part of the viral genome – for example Viral RNA or Antigen.  

      A sample is prepared by extracting the chosen section of the genome, and then PCR (Polyamerase Chain Reaction) techniques are used to amplify (replicate) the genome section, ready for detection.

      Viral RNA Tests

      This type of test detects the RNA (Ribonucleic acid) contained within the SARS-CoV-2 virus.

      It is this type of test, for RNA, that is recommended by The World Health Organisation for COVID-19 diagnosis.

      Antigen Tests

      Antigens are molecular structures on the surface of viruses that are recognized by the immune system and are capable of triggering an immune response.

      Antigen tests detect the presence of the SARS-CoV-2 virus by looking for the antigen on the surface of the virus.

      Randox COVID-19 Test

      The Randox COVID-19 test, as recommended by the World Health Organisation, detects the RNA contained within the SARS-CoV-2 virus.

      After sample extraction and amplification, the virus is detected on our patented Randox Biochip Technology platform.

      The Randox Biochip, which can run multiple tests simultaneously, performs two tests for COVID-19 – one specific and one confirmatory – as recommended by the WHO. This delivers extra assurance of the correct diagnosis and avoids the need to repeat the test.

       

      Antibody (Serology) Tests

      Antibody (also known as serology) tests, are usually performed on a patient blood sample, and look for antibodies (a type of protein) that may have been developed by the patient’s immune system to fight off disease.

      If present, antibodies may provide a degree of immunity for the patient against COVID-19 in the future.

      However, there is still much unknown about the body’s antibody response to COVID-19, including;

      • Whether all patients who have been infected with SARS-CoV-2 will generate antibodies (recent studies and news reports indicate that this isn’t the case. Click here for an example.)
      • Whether those who have had more severe symptoms as a result of COVID-19 will produce more antibodies than those who had mild symptoms, or were asymptomatic.
      • If antibodies from other coronaviruses previously experienced by the patient may be enough to fight off the virus, therefore eliminating the need for COVID-19 specific antibodies.
      • How long any COVID-19 specific antibody response will last for.
      • How much future immunity is provided by COVID-19 antibodies. Will it prevent the patient from being infected, or will future infection just be less severe?

      If antibodies for the SARS-CoV-2 virus are present this can give an indication that the patient has been previously infected with COVID-19. Antibody tests do not confirm the real-time presence of the virus in your system.

      For example, a negative antibody result does not necessarily mean the body has not been exposed to the SARS-CoV-2 virus. It could in fact, be currently infected, but has not yet generated antibodies. A diagnostic test will confirm current presence of the virus.

       

      Therefore, it is recommended that antibody tests are used in tandem with a diagnostic test to determine a complete overview of the patient’s COVID-19 status.

      Randox Health currently offers both diagnostic testing and antibody testing for SARS-CoV-2 (COVID-19).

      A combination of diagnostic and antibody testing is available for individual purchase, or as part of our ‘Back to Business’ COVID-19 testing service, for staff screening.

      Visit Randox Health to find out more.

      Want to know more about Randox?

      Contact us or visit our homepage to view more.

      Our Randox Products and Services

      REAGENTS

      RX SERIES

      ACUSERA

      BIOCHIP


      COVID-19 Laboratory Tools for Disease Management

      News       About Us       COVID-19 Lab Tools

      17 June 2020

      COVID-19 – Laboratory Tools for Disease Management

      In addition to tests for the detection of SARS-CoV-2, the virus that causes COVID-19, laboratory diagnostics play a pivotal role in patient management, risk stratification, monitoring of disease progression, associated complications and response to treatment.

      Randox offers a comprehensive range of laboratory solutions including; diagnostics reagents, revolutionary Biochip technology and quality control designed to provide clinicians with valuable insights into disease severity ultimately helping to improve patient care.

      Patients with comorbidities such as diabetes mellitus, cardiovascular disease (CVD) and chronic kidney disease (CKD) are particularly susceptible to COVID-19 infection and are at greater risk of developing severe illness.  The Randox portfolio may also be used to diagnose and monitor such at risk patients with underlying health concerns.

       

      Biochemistry Reagents

      Our extensive test menu comprises 113 assays, including many unique tests and a range of biomarkers designed to assist laboratories when screening for a variety of COVID-19 related health issues.

      Randox Reagents are internationally recognised as being of the highest quality; producing accurate and precise results.  Applications are available detailing instrument-specific settings for the majority of clinical chemistry analysers.

      C-Reactive Protein (CRP)

      Elevated markers of inflammation and infection such as CRP may indicate severe viral infection. CRP is elevated in up to 86% of COVID-19 patients who are admitted to hospital. Testing for CRP is useful in assessing prognosis, and when monitoring improvement. It is recommended that CRP is measured at baseline and then at intervals, a sudden increase in levels will prompt surveillance for secondary infection or other cause of deterioration.

      Ferritin

      As an acute phase reactant, Ferritin levels increase in response to inflammation. High levels have been identified in approximately 60% of individuals hospitalised as a result of COVID-19 infection. In critically ill patients, elevated Ferritin levels may be indicative of a cytokine storm and secondary haemophagocytic lymphohistiocytosis, a hyperinflammatory syndrome associated with organ failure.

      Liver Function Tests (Albumin, ALT, AST, Bilirubin)

      Patients with COVID-19 may be at higher risk of liver injury or impairment of liver function. Liver function markers such as ALTAST and Bilirubin are notably higher in more severe infections, decreased albumin levels have also been documented in severe cases. Drug induced liver injury as a result of COVID-19 treatment should not be ignored and should be monitored.

      Renal Function Tests (Creatinine, Cystatin C)

      Emerging evidence suggests that SARS-CoV-2 may directly affect kidney function, as such COVID-19 patients should be assessed for Acute Kidney Injury (AKI) on admission to hospital and monitored throughout their stay. AKI can lead to worse outcomes for patients.

      Lactate Dehydrogenase (LDH)

      LDH levels may be a convenient marker for the identification of COVID-19 patients at higher risk of developing severe respiratory failure. It is well documented that high LDH levels are indicative of haematological malignancy and acute lung injury. LDH levels might therefore reflect tissue necrosis related to immune hyperactivity and thus are related to poor clinical outcomes in individuals with COVID-19.

      G6PDH

      Chloroquine has been investigated as a potential treatment for COVID-19, the anti-malaria drug however could have devastating consequences for those with a G6PDH deficiency. G6PDH deficiency is a genetic disorder affecting the red blood cells, causing them to break down prematurely. The most common complication of deficiency is haemolytic anaemia. An estimated 400 million people globally have G6PDH deficiency, it is most common in certain parts of Africa, Asia, the Mediterranean and Middle East.

       

      Randox Biochip Solutions

      Randox Biochip technology is extremely versatile with applications in not only the diagnosis of COVID-19 but also the identification of individuals at risk of developing more severe illness.  

      Unique to Randox, Biochip technology is capable of simultaneous detection of a panel of  related disease markers.  An extensive range of  Biochip panels are available, each optimised to provide the best performance.

      Cytokine Arrays

      Cytokines play a vital role in the immune system and are known to be involved in the body’s response to a variety of inflammatory and infectious diseases. The over stimulation of these cytokines in response to infection is referred to as a ‘cytokine storm’ and strongly correlates with poor disease outcomes. Cytokine storms are a common complication of SARS-CoV-2 infection triggering viral sepsis, where viral replication and excessive, uncontrolled systemic inflammation may lead to pneumonitis, Acute Respiratory Distress Syndrome (ARDS), respiratory failure, shock, multiple organ failure, secondary bacterial pneumonia, and potentially death. Cytokines such as IL-6 appear to be elevated in patients with more severe illness and may be used to monitor response to treatment as levels decrease as the condition improves.

       

      Quality Control Solutions

      Randox offer a range of Quality control and External Quality Assessment (EQA) solutions designed to ensure the accuracy and reliability of patient testing.

      Haematology

      Decreased blood counts have been frequently identified in COVID-19 patients and may be indicative of a decreased immunological response to the virus, bacterial infection or consumption.

      Blood Gas

      Blood Gas tests are used to help diagnose and monitor critically ill patients in intensive care units (ICU) and emergency departments. Blood Gas testing continues to play a critical role in the management of COVID-19 patients providing an indication of a patient’s oxygenation levels. Monitoring of these levels will enable healthcare professionals to make ventilator adjustments if required.

      Cardiac Markers

      Increased levels of cardiac markers including Troponin and CK-MB may be associated with a higher mortality rate in COVID-19 patients.

      Coagulation

      Patients with severe COVID-19 infection are more likely to have coagulopathy, a condition in which the bloods ability to form clots is impaired. Activation of blood coagulation factors such as Prothrombin Time (PT) and D-dimer are significant predictors of disease severity and mortality.

      Procalcitonin

      Procalcitonin is an acute phase reactant released by most tissues during inflammation and is particularly associated with bacterial infection. Although it is not usually elevated in viral infections such as SARS-CoV-2 levels may increase as a result of severe systemic inflammation. It may also be used to help detect secondary infections.

      For further information about any of the above Laboratory Tools for COVID-19 Disease Management please email marketing@randox.com

       

      Want to know more about Randox?

      Contact us or visit our homepage to view more.

      Our Randox Products and Services

      REAGENTS

      RX SERIES

      ACUSERA

      BIOCHIP


      We Are Randox | How Sean Mills became Production Supervisor at Randox

      About Us       News        Contact

      15 June 2020

      How Sean Mills became Production Supervisor at Randox

       

      We Are Randox | How Sean Mills became Freeze Dry Production Supervisor at Randox

      In support of our new £30m COVID-19 laboratories, we are hiring 200 new staff across Engineering, Manufacturing and Science.

      For an idea of what it’s like to work in Manufacturing at Randox, we spoke to Freeze Dry Production Supervisor Sean Mills.

      Sean spoke to us about what his job entails, the skills required for the role, and what advice he would give someone on their first day of a new job.

      Name: Sean Mills

      Job Title: Supervisor

      Department: Freeze Dry Production

      Sean, what route did you take to get your job?

      At school my favorite subjects were Biology and Physical Education, and though I completed my A-levels, I turned down the opportunity to go to the university I had selected. I just knew that going to university was not for me. I had previous work experience working in a laboratory, having volunteered in the Belfast City Hospital labs, as well as some other manufacturing experience from various summer jobs, so I applied for a Manufacturing Operative job with Randox. I started with the company on 3rd November 2008 and have progressed throughout the department.  I worked my way up to Laboratory Technician, then Lead Laboratory Technician, and now Departmental Supervisor.

      Can you give us a quick summary of what your job entails?

      My main responsibility is the day-to-day running of the Randox Freeze Dry Production team, which starts every day with a morning meeting to go over our schedule. I review our workload, determine what sites we will be working at, and delegate tasks to different members of the team. I also check if there were any issues from the previous day that we need to look at. As Supervisor I liaise with the Planning Team to manage our work to meet production deadlines, and with the Purchasing and Stock departments to order materials that we need to complete our work.  I like to be practical and hands-on so in addition to my administrative duties I also do manual work like loading and unloading freeze driers.

      Is this what you always wanted to do?

      When I was younger I was unsure what I wanted to do for full time employment but this is my 12th year as part of the Randox family and I am so glad I chose to work here. It has been a fantastic environment in a dynamic role that continues to challenge me every year. In February this year I was really proud to be named Randox Employee of the Year 2020.

       Were there any particular essential qualifications or experience needed?

      For the job I originally applied for there were no specific requirements other than a GCSE in Maths and English. Given the work we do, I would definitely say that an understanding of Maths and English are important.

      Are there alternative routes into the job?

      One of the great things about Randox is that you can change roles internally if you want to try a new discipline or have a new experience. As such there is a real mix of backgrounds across all teams in the company. Some people join us after university or after working for other companies, and others like myself begin their careers here and then progress within their department.

      What are the main personal skills your job requires?

      Organisational and numerical skills, as well as excellent communication and good time management, are definitely essential in my role. The ability to follow health and safety procedures and work off your own initiative are also key.

      What are the best and most challenging aspects of the job?

      Having worked within manufacturing for over 10 years now I am no stranger to a lot of hard work in order to meet a deadline. These pressure situations are something I enjoy as they allow you to think of ways to improve manufacturing processes. I am lucky I work with a fantastic team and have a great manager who has also worked his way up in the department. He is a great mentor.

      Why is what you do important?

      My team are responsible for manufacturing the highest quality product to facilitate patient diagnosis. My own role specifically is important to keep the team motivated and ensure everything is in place to allow them to complete their job. I am here to train new staff, help problem solve, and use my experience to support my team when they need it.

      If you weren’t doing this what would you like to do?

      If I wasn’t working in Manufacturing I would like to work in the Police or Fire Service.

      What is the one piece of advice you would give to yourself on your first day?

      To anyone about to begin their first day in a new job I would give reassurance that they don’t need to be nervous. I would also encourage asking as many questions as possible until you are 100 percent sure what you’re doing and what’s expected from you. With any job there is always something new to learn and people you can learn from. No one knows everything, and everyone needs a little help now and again.

       Describe your ideal day off.

      On my ideal day off I would get up early to play a round of golf or go to the gym. Then I would spend the day with my partner, enjoy a nice meal and end the day by watching a movie.

      And finally, what’s the key to any successful job search?

      I have been happily working at Randox for almost 12 years, so I think that means my last job search was a successful one! My advice would be to apply for a job that excites or interests you.

       

      We are delighted to have Sean with us at Randox as part of our hard-working manufacturing team.

       

      For current vacancies at Randox please visit careers.randox.com

      For more We Are Randox stories about our amazing colleagues, make sure to follow us on Facebook, Instagram and Twitter and follow the hashtag #WeAreRandox.

      For further information please email recruitment@randox.com or phone 028 9442 2413.

      Want to know more?

      Contact us or visit our Randox Careers

      Find out more about Randox Careers

      Careers News

      Vacancies

      Our People

      Careers Website


      Cytokine testing for COVID-19 risk stratification and treatment monitoring

      News       About Us       Cytokine Biochips

       

      11 June 2020

      Cytokine testing for COVID-19 risk stratification and treatment monitoring

      On Biomedical Science Day 2020, an innovative method of monitoring treatment efficacy and recovery of COVID-19 has been unveiled by global diagnostics company Randox Laboratories.

      The test, which looks for the presence of cytokines (a type of small protein) is performed on Randox’s patented Biochip Technology, which can simultaneously detect multiple analytes from a single patient sample.

      Cytokines play a vital role in the immune system and are known to be involved in the body’s response to a variety of inflammatory and infectious disease, such as COVID-19.

      Lynsey Adams, Randox Marketing Manager, commented;

      “Cytokine storms, which are the overstimulation of cytokines in response to infection, are a common complication of severe cases of COVID-19, and can trigger excessive, uncontrolled systemic inflammation.

      “The monitoring of cytokine proteins therefore offers a unique opportunity to identify patients who, as a result of this viral sepsis, are at risk of poor disease outcomes including pneumonitis, Acute Respiratory Distress Syndrome, respiratory failure, shock, or even organ failure.

      “Treatment for any infection, COVID-19 included, is most effective when administered at an early stage, and so the detection of cytokine storms within COVID-19 patients could provide vitally important information that will direct the appropriate patient care pathway and facilitate improved patient outcomes.”

      The comprehensive cytokine testing menu from Randox comprises of 26 different cytokines, across four different biochip panels.

      Designed to make cost, time and resource savings for a range of diagnostic laboratories, Randox Cytokine Biochips can detect up to 12 cytokines and growth factors from a single patient sample.

      Lynsey continued;

       “The multiplex capabilities of the Randox Biochip will provide clinicians with a more comprehensive picture of the patient’s condition.

      “Compatible with our Evidence and Evidence Investigator analysers, which are capable of processing 2960 and 2376 tests per hour respectively, Randox Cytokine Biochip panels offer a comprehensive testing method for these proteins which play such a central role in the immune system.”

      In addition to COVID-19 risk stratification, cytokine testing has also been linked to monitoring for allergies, vascular diseases, cancer, and a range of autoimmune diseases.

      Key Benefits of Randox Cytokine Testing

      • Simultaneous detection of up to 12 cytokines and growth factors from a single patient sample
      • Fully automated and semi-automated testing platforms available to suit all laboratory throughputs
      • Comprehensive test menu comprising 26 cytokines, cytokine receptors and growth factors
      • Suitable for use with serum and plasma samples
      • Excellent analytical performance
      • Availability of complementary quality controls for a complete testing package

      For more info please visit www.randox.com/cytokine-testing-solutions/, email marketing@randox.com or phone 028 9442 2413

      Want to know more about Randox?

      Contact us or visit our homepage to view more.

      Our Randox Products and Services

      REAGENTS

      RX SERIES

      ACUSERA

      BIOCHIP


      We Are Randox | How Ciara Taylor became R&D Team Leader at Randox

      About Us       News        Contact

      10 June 2020

      How Ciara Taylor became R&D Team Leader at Randox

       

      We Are Randox | How Ciara Taylor became Clinical Immunoassay R&D Team Leader at Randox

      In support of our new £30m COVID-19 laboratories, we are hiring 200 new staff across Engineering, Manufacturing and Science.

      For an idea of what it’s like to be a scientist at Randox, we spoke to R&D Team Leader Ciara Taylor.

      Ciara spoke to us about the route she took to her current role, what advice she would give someone following a similar career path, and what makes her job so important.

      Name: Ciara Taylor

      Job Title: R&D Team Leader

      Department: Clinical Immunoassay R&D

       

      Ciara, can you give us a quick summary of what your job entails?

      Our team works on the research and development of new clinical diagnostic tests for a variety of common health conditions, such as heart disease.  We carefully design and execute laboratory experiments to ensure our tests perform at an exceptionally high level for hospitals and laboratories around the world.   

      What did you study and where?

      I studied a four-year integrated Chemical Engineering Masters degree at Queen’s University Belfast.  It was an ideal choice for me as it encompassed areas of the subjects I had enjoyed at school; Chemistry, Physics, Biology and Maths. I gained a lot of experience in research during my final year industrial project.

      Ciara Taylor

      Give a brief outline of your career to date

      I finished my university degree in 2016.  I worked for an Engineering consultancy firm for 6 months, and then spent some time travelling before joining Randox in October 2017. In my first year I spent time learning about the science behind immunoassay development and how to apply to our research work.  At the end of 2018, I was promoted to Research and Development (R&D) Team Leader, giving me more responsibility over the training of staff, and the progress of new projects, from initial concept and feasibility to product validation. I have also had the opportunity to travel and represent the company in conferences, events and career days. 

      Is this what you always wanted to do?

      When I was younger I honestly had no idea what my ideal job would be.  I simply knew that I wanted a dynamic role that involved working with people on challenging and interesting projects, which is exactly what I have here at Randox.  I love the variety and opportunity that a global company like Randox offers as we are always trying to evolve and keep up with the latest industry demand. Currently every department is working together to process large-scale testing for COVID-19, as part of the government’s national testing programme.

      Were there any particular essential qualifications or experience needed?

      We have people of varying degree backgrounds in our team including Chemistry, Chemical Engineering, Biochemistry, Biomedical, Biological or Pharmaceutical Sciences. Experience in a similar R&D capacity is also helpful, though we offer full training to those who may have little experience specifically in diagnostics, but who possess a general science background. 

      Are there alternative routes into the job?

      Whilst I joined Randox as a graduate R&D scientist following university, there are other routes available. Some of my colleagues began their careers by doing a placement year with Randox or by taking part in our Graduate Programme, in which graduates rotate across different areas of the business to find a job best suited to their skills and interests.  Also available as an option is the Randox APEX scheme, which gives first year university students a summer and a third-year placement, and a job offer upon graduating.  Naturally we also have a lot of PhD graduates join R&D, as they are ideal candidates for conducting research.  Another route, if you don’t have the A-Levels for a university degree, is to go to a Technical College and gain an equivalent qualification in a science discipline.  This could lead to a placement opportunity and later job with Randox.

      What are the best and most challenging aspects of the job?

      The best part of working in Randox is the people you work with. We work very collaboratively across different departments, and our staff come from a wide variety of backgrounds, so I am constantly learning from everyone around me and bouncing ideas off different people with different skillsets.

      The most challenging aspect is the same in every R&D role – sometimes the initial feasibility experiments just don’t give the results you had expected.  The rewarding part lies in solving the problem and making a breakthrough in your research project.

      Why is what you do important?

      The development of clinical diagnostic tests has a direct impact on the quality of healthcare that people receive around the world.  It is rewarding to be part of a global company that is trying to improve people’s lives by providing a more personalised diagnosis using the tests we develop.  As a company, Randox is continually investing money into the research of novel clinical biomarkers and testing platforms, showing its commitment to the improvement of diagnostics and ultimately, patient outcomes.

      What advice would you give anyone looking to follow a similar career path?

      If you are interested in R&D, keep your options and searches open.  I didn’t know how much I would enjoy clinical R&D until I started at Randox.  It makes a difference when you are genuinely interested and take pleasure in the work you do.  Previous lab experience is ideal, so I would recommend trying to do a placement or getting some relevant work experience, especially if your degree doesn’t include much practical lab work. 

      If you weren’t working in Clinical Immunoassay R&D what would you like to do?

      I would still love to be in a research role, perhaps in renewable or clean energy sources.

      Describe your ideal day off

      My ideal day off involves exercise or eating! I would go for a swim, yoga or a long walk, and then go out for dinner. I love trying new restaurants.

      We are delighted to have Ciara with us at Randox as part of our incredibly talented R&D team.

       

      For current vacancies at Randox please visit careers.randox.com

      For more We Are Randox stories about our amazing colleagues, make sure to follow us on Facebook, Instagram and Twitter and follow the hashtag #WeAreRandox.

      For further information please email recruitment@randox.com or phone 028 9442 2413.

      Want to know more?

      Contact us or visit our Randox Careers

      Find out more about Randox Careers

      Careers News

      Vacancies

      Our People

      Careers Website


      CE marking granted to Quality Control for newborn infectious disease tests

      08 June 2020

      CE marking granted to Quality Control for newborn infectious disease tests 

      ToRCH Quality Controls to support the accuracy and reliability of infectious disease testing in newborns, have been granted CE marking.

      The controls for ToRCH, which is a blood test screening to detect infectious diseases including toxoplasmosis, rubella, cytomegalovirus, and herpes simplex, are available from global diagnostics company Randox Laboratories, and are used to ensure accurate ToRCH test and system performance.

      Manufactured from human plasma, each control is designed to react to the test system in the same manner as the patient sample, helping laboratories to meet ISO 15189:2012 for quality and competence.

      Lynsey Adams, Randox Quality Control Manager, commented;

      “The CE marking of the ToRCH controls from Randox will be a game-changer for clinicians and patients alike, by facilitating early, accurate and comprehensive diagnoses of infectious diseases in newborns, that allow for the best possible patient outcomes.

      “Ultimately, these ToRCH controls will guarantee quality assurance in laboratories performing ToRCH screening in newborns.”

      Randox ToRCH Controls are also multi-analyte and therefore, testing can be consolidated to just a small number of vials to save laboratories valuable space and time.

      In addition to ToRCH, Randox Infectious Disease Quality Controls also include quality control material for Lyme Disease, Epstein-Barr virus, HIV, Hepatitis A virus, Human T-lymphotropic virus, Cytomegalovirus, and Varicella zoster virus (Chickenpox or Shingles).

      Lynsey continued;

      “Unlike analyser-specific tests, these controls can be used across a wide range of laboratory technologies, and complement our already existing RIQAS Serology EQA programmes to provide laboratories with a complete QC solution from a single supplier.

      “With a working stability of 60 days at 2°c to 8°c which keeps waste and costs to a minimum, Randox Infectious Disease Controls are set to revolutionise serology testing and provide reliable, accurate results time and time again.”

      Randox Infectious Disease Controls are ideal for microbiology and virology laboratories, blood banks, public health laboratories or clinical laboratories performing serology testing.

      Key benefits of the Randox Infectious Disease Controls;

      • User-friendly – all samples are provided in a liquid, ready-to-use format
      • Commutable – manufactured from human plasma, each control reacts to the test system in the same manner as a patient sample
      • Versatility – designed to deliver an independent, unbiased assessment of performance with any immunoassay instrument
      • Stability – working stability of 60 days ensures waste and costs are kept to a minimum
      • Multi-marker – helps reduce the number of individual controls required
      • Clinical relevance – designed to challenge clinically-relevant levels, samples will ensure accurate and reliable instrument performance

      For more information visit https://www.randox.com/torch-controls/

      QUALITY CONTROL

      REAGENTS

      RX SERIES


      Request a meeting
      ×
      Make an Enquiry - RX series
      ×
      Make an Enquiry - Reagents
      ×
      Kit Insert Request - Reagents
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Kit Insert Request - Reagents
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Make an Enquiry - Reagents
      ×
      Make an Enquiry - Quality Control
      ×
      Make an Enquiry - RIQAS
      ×
      Make an Enquiry - RIQAS
      ×
      Make an Enquiry - Quality Control
      ×
      Make an Enquiry
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Make an Enquiry - Biochip
      • This field is for validation purposes and should be left unchanged.
      ×
      Make an Enquiry - Molecular
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      • This field is for validation purposes and should be left unchanged.
      ×
      Make an Enquiry - Future Diagnostics
      ×
      Make an Enquiry - RX series (Product)
      ×
      Make an Enquiry - Quality Control
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Make an Enquiry - RIQAS
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Make an Enquiry - Reagents
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      Por favor, introduzca sus datos para ver nuestro último seminario
      ×
      Wyślij zapytanie
      • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje Polityki Prywatności.
      ×
      Wyślij zapytanie
      • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
      ×
      Wyślij zapytanie
      • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
      ×
      Wyślij zapytanie
        Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności .
      ×
      귀하의 문의 사항 제출
        Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      ×
      귀하의 문의 사항 제출
      ×
      귀하의 문의 사항 제출
      ×
      귀하의 문의 사항 제출
      ×
      Downloads
      ×
      Contact

      <p>

        Randox Clinical Chemistry Products Join the Randox Laboratories Mailing List * I would like to receive emails with new product releases and updates from Randox Laboratories, market trends, and more. I do not want to receive email marketing from Randox. Signing up to our mailing list is quick and easy. We do not want to send you any spam or junk emails, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promises never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
      </p>

      ×
      Enquire Now - Coronavirus Testing
      • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details safe and secure. Read more in our Privacy Policy.
      ×